DrugDashboards

Guaifenesin and Codeine Phosphate

Guaifenesin and Codeine Phosphate · GUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mL · Solution · Oral · PAI Holdings, LLC

NDC 00121-0775-16 · 473 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.0331 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.025$0.05$0.075Nov 2013Sep 2026$0.0331
155 price points · per MLSource: CMS NADAC

Medicaid spend (2025)

$448,194
36,167 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 4 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for guaifenesin and codeine phosphate (other) in the next 90 days

sole-source market · price up 5% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJan 7, 2025
    PAI Holdings, LLC. dba Pharmaceutical Associates IncSuperpotent; sodium benzoate preservative

Manufacturers of Guaifenesin and Codeine Phosphate (Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsGUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mLAug 26, 2026Sep 2, 2026
Cardinal Health 107, LLCCODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLCGUAIFENESIN 200 mg/10mL; CODEINE PHOSPHATE 20 mg/10mLAug 26, 2026Sep 2, 2026
PAI Holdings, LLCGUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mLAug 26, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.GUAIFENESIN 100 mg/5mL; CODEINE PHOSPHATE 10 mg/5mLAug 26, 2026Sep 2, 2026
PAI Holdings, LLCGUAIFENESIN 10 mg/5mL; CODEINE PHOSPHATE 100 mg/5mLJul 22, 2026Aug 22, 2026
A-S Medication SolutionsGUAIFENESIN 10 mg/5mL; CODEINE PHOSPHATE 100 mg/5mLJul 22, 2026Aug 19, 2026
PAI Holdings, LLCGUAIFENESIN 20 mg/10mL; CODEINE PHOSPHATE 200 mg/10mLJul 22, 2026Aug 19, 2026
Preferred Pharmaceuticals Inc.GUAIFENESIN 10 mg/5mL; CODEINE PHOSPHATE 100 mg/5mLJul 22, 2026Aug 19, 2026
PAI Holdings, LLCCODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 19, 2026
A-S Medication SolutionsCODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026
PAI Holdings, LLCCODEINE PHOSPHATE 20 mg/10mL; GUAIFENESIN 200 mg/10mLJul 15, 2026Jul 15, 2026
Preferred Pharmaceuticals Inc.CODEINE PHOSPHATE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Guaifenesin and Codeine Phosphate — NDC 00121-0775-16," retrieved September 3, 2026, https://drugdashboards.com/drug/00121077516.

Free to cite with attribution — see how the data is put together.